Acupoints and lymphatic vessels are distributed in various parts of our body, and there are also many on the neck. The editor suggests that everyone can massage more appropriately when washing their face. Lymphocytic lesions may lead to lymphoma. Today, I want to take you to understand the staging of non Hodgkin lymphoma. After the disease is staged, the treatment method may also vary. The most correct way is to prescribe the right medicine.
Currently, the Ann Arbor system is being used in stages. The Ann Arbor system, although originally designed for Hodgkin's lymphoma, is also commonly used for clinical staging of non Hodgkin's lymphoma. But it should be understood that for NHL, clinical staging is not as important as Hodgkin's lymphoma. Especially for progressive or highly progressive NHL, even if the clinical staging is relatively limited, it should still be considered a systemic disease and receive systematic treatment with emphasis.
1. Invasion of a single lymph node area (I) or a single extranodal site (IE)
2. II invades two or more lymph node regions, but all on the same side of the diaphragm (II), may be accompanied by localized extranodal organ invasion on the same side (IIE)
3. There is invasion in both the upper and lower lymph node regions of the diaphragm (III), which may be accompanied by localized extranodal organ invasion (IIIE) or splenic invasion (IIIS), or both invasion (IIIES).
4. IV involves extensive invasion of one or more extranodal organs or tissues outside the lymph nodes, spleen, and pharyngeal lymph nodes, with or without lymph node enlargement.
Patients in each stage are divided into two categories, A and B, based on the presence or absence of symptoms B. Symptoms B include: unexplained weight loss>10% within 6 months; Fever of unknown cause (above 38OC); night sweat.
For non Hodgkin's lymphoma of primary skin, the TNM staging system for cutaneous T-cell lymphoma is more valuable in guiding treatment and predicting prognosis. TNM staging system for cutaneous lymphoma, early stage: IA 10% rash or macula (T1); IB ≥ 10% rash or spotted rash (T2); IIA T1-2， Lymph nodes are enlarged but biopsy is negative. Mid stage: IIB skin tumor (T3); Red skin disease (T4); IVA T1-4， Lymph nodes are enlarged and biopsy results are positive.
